ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1564	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	treatment 0.456448 cancer treatment 0.208981 vocal cords 0.463035 Laryngeal Cancer Treatment 0.208444 NCI-supported cancer 0.201905 cancer cells 0.32099 stage laryngeal cancer 0.221553 body 0.20156 chemotherapy 0.227934 PDQ cancer information 0.235798 larynx 0.286996 clinical trial search 0.245354 Hyperfractionated radiation therapy 0.214818 laryngeal cancer spreads 0.200731 National Cancer Institute 0.254821 laryngeal cancer 0.644668	clinical trials 0.596105 metastatic laryngeal cancer 0.202273 cancer information summary 0.213869 clinical trial 0.439358 Recurrent laryngeal cancer 0.222324 new treatment 0.207333 patients 0.231814 neck 0.206846 original tumor 0.252057 cancer clinical trials 0.262761 stage 0.247854 lymph nodes 0.238789 lymph node 0.41143 radiation therapy 0.83207 cancer 0.992267	CLICK HERE
1584	National Cancer Institute	Html	en	Anal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of anal cancer.	cancer treatment 0.433322 diagnose anal cancer 0.423593 Anal Cancer Treatment 0.419952 metastatic anal cancer 0.412176 Frequent anal redness 0.384126 body 0.434753 PDQ cancer information 0.446236 clinical trial search 0.504831 anal cancer spreads 0.410812 clinical trials 0.887836 cancer information summary 0.419039 clinical trial 0.647154 anus 0.449257 patients 0.429875 treatment clinical trial 0.380816 NCI PDQ cancer 0.384659 malignant tumor cells 0.380765 radiation therapy 0.718553 Treatment Editorial Board 0.382929 human immunodeficiency virus 0.375987 rectum 0.3805 General information 0.426863 general cancer information 0.376766 treatment 0.612453 abdominoperineal resection 0.403255	receptive anal intercourse 0.384527 new cancer treatments 0.377037 NCI-supported cancer 0.425485 cancer cells 0.46124 Cancer Information Service 0.376813 sphincter muscles 0.384557 treatment clinical trials 0.40741 National Cancer Institute 0.461854 Recurrent anal cancer 0.435676 new treatment 0.505194 external-beam radiation therapy 0.454262 IIIA anal cancer 0.402258 IIIB anal cancer 0.401297 anal cancer 0.792189 new treatment options 0.426789 anal opening 0.376839 cancer clinical trials 0.506964 stage 0.400723 Local resection 0.453758 tumor 0.401265 comprehensive cancer information 0.375327 internal radiation therapy 0.496063 cancer 0.970468 information 0.453326	CLICK HERE
1665	National Cancer Institute	Html	null	Last Days of Life (PDQ®)–Patient Version	Expert-reviewed information summary about care during the last days to last hours of life, including common symptoms, ethical dilemmas that may arise, and the role of the oncologist in caring for patients and their families during this time.			CLICK HERE
1689	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood central nervous system germ cell tumors.	craniospinal irradiation 0.568926 intracranial germinoma 0.542559 survival rates 0.505415 excellent survival rates 0.497286 endodermal sinus tumor 0.492396 germ cell tumor 0.543477 chemotherapy 0.510034 reduced-volume radiation therapy 0.492394 ifosfamide based chemotherapy 0.484152 Tumors Treatment Overview 0.506029 primordial germ cells 0.489907 focal radiation therapy 0.518434 pure germinomas 0.484971 Radiat Oncol Biol 0.492523 tumor markers 0.56413 radiation therapy doses 0.490668 CNS germ cell 0.55586 tumor markers AFP 0.505621 cerebrospinal tumor markers. 0.502663 conventional whole-brain irradiation 0.482504 whole-ventricular radiation therapy 0.492409 CSF AFP levels 0.509387 nongerminomatous germ cell 0.513106 cell tumor study 0.490435 yolk sac tumor 0.491117	germ cell theory 0.506108 common solid tumor 0.502347 germinomatous germ cell 0.4915 primary chemotherapy 0.487412 radiation therapy 0.751812 et al. 0.485468 Low-dose craniospinal irradiation 0.484891 CNS GCTs 0.523584 whole-ventricle radiation therapy 0.491449 SIOP CNS GCT 0.490345 brain tumor treatment 0.516207 primary brain tumors 0.544753 neoadjuvant chemotherapy results 0.491554 Pediatr Blood Cancer 0.568832 response-based radiation therapy 0.486149 radiation treatment volume 0.488339 boost radiation therapy 0.486976 nervous system tumors 0.483298 Brain Tumor Study 0.49693 Oncol Biol Phys 0.49429 specific chemotherapy regimen 0.484857 intracranial germ cell 0.58985 germ cell tumors 0.911962 radiation therapy fields 0.485192	CLICK HERE
1909	National Cancer Institute	Html	es	Tratamiento de la leucemia mielógena crónica (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mielógena crónica.	siguientes procedimientos 0.425256 células madre 0.845072 Chronic Myelogenous Leukemia 0.438357 leucemia linfoblástica aguda 0.438362 hueso compacto 0.417479 enlace drugs approved 0.436902 cromosoma filadelfia 0.526385 célula madre mieloide 0.437781 Sudores nocturnos 0.404959 células anormales.ampliar aspiración 0.417986 enlace medicamentos 0.404489 National Cancer Institute 0.403419 siguientes riesgos 0.40277	Instituto Nacional 0.405884 célula madre linfoide 0.438967 PDQ Tratamiento 0.410126 hijos.ampliar cromosoma filadelfia 0.412419 leucemia mielógena 0.99599 Physician Data Query 0.412686 laboratorio piezas 0.403757 leucemia mieloide aguda 0.437955 siguientes exámenes 0.405471 célula madre 0.512002 células sanguíneas maduras 0.448469 ósea elabora células 0.429135 siguientes sumarios 0.40998	CLICK HERE
1958	National Cancer Institute	Html	es	Tratamiento del retinoblastoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del retinoblastoma en niños.	siguientes procedimientos 0.348249 células madre 0.681334 células madre ayuda 0.327411 pequeña cantidad 0.314739 quimioterapia regional.También 0.356888 siguientes especialistas 0.315369 rayos x 0.316905 huesos.ampliar exploración 0.316446 sección información 0.311156 ondas sonoras 0.352613 efectos tardíos 0.419814 PDQ Efectos tardíos 0.340519 estadio iva 0.318526 tejidos cercanos.ampliar radioterapia 0.346215 quimioterapia sistémica 0.959376 líquido cefalorraquídeo 0.342894 National Cancer Institute 0.310552	retinoblastoma causa efectos 0.427797 estadios iiia 0.316715 Instituto Nacional 0.318729 PDQ Tratamiento 0.331936 determinados cambios 0.322309 International Retinoblastoma Staging 0.571406 Drugs Approved 0.312346 gen rb1 0.821065 Physician Data Query 0.339103 sistema nervioso central 0.324254 posibles efectos 0.313593 Retinoblastoma Staging System 0.572567 siguientes situaciones 0.322957 placa ayuda 0.311711 haz láser 0.317188 siguientes pruebas 0.320835	CLICK HERE
2011	National Cancer Institute	Html	es	Exámenes de detección del cáncer de pulmón (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar o vigilar el cáncer de pulmón.	lung cancer screening 0.491865 Berg CD 0.308884 UK Lung Cancer 0.309828 Cooperative Early Lung 0.306877 Lung Cancer Study 0.310626 lung cancer 0.996403 Reduced lung-cancer mortality 0.308509 American Cancer Society 0.314872 Sloan-Kettering Lung Study 0.306329 Extended lung 0.305748 lung-cancer screening 0.305282 Lung Screening Trial 0.34779 Preventive Services Task 0.315666 early lung cancer 0.370281 Cancer Res 0.308506 screening results 0.305543 exámenes detección 0.3124 Screening Trial 0.41076 lung-cancer mortality with 0.308638 Randomized Danish Lung 0.306065 CT screening 0.322848 Natl Cancer Inst 0.348878 small lung 0.309116 Lung Cancer Risk 0.310447 from baseline screening 0.305357	More lung 0.305626 Screening Trial with 0.311542 early stage lung 0.306471 Is curable lung 0.306471 cytologic screening 0.312546 Hocking WG 0.305973 Hopkins Lung Project 0.306129 CT screening according 0.305575 Danish Lung Cancer 0.338861 Lung Cancer Action 0.32014 randomised danish lung 0.306155 National Lung Screening 0.345051 Intern Med 0.314222 lung cancer detection 0.362796 Services Task Force 0.31539 Randomized Lung Cancer 0.310797 from semi-annual screening 0.30542 PLCO Cancer Screening 0.310194 Mayo Lung Project 0.341943 lung cancers detected 0.306094 Memorial Sloan-Kettering 0.306282 Cancer Action Project 0.310925 Lung Project revisited 0.306785 Cancer Screening Trial 0.390805	CLICK HERE
2115	National Cancer Institute	Html	es	Prevención del cáncer de hígado (hepatocelular) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer hepatocelular y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	chronic hepatitis b 0.391786 chronic hepatitis c 0.392121 available online 0.329517 American Cancer Society 0.362594 tt virus dna 0.321147 largo plazo 0.314356 with hepatocellular carcinoma 0.362577 hepatitis e 0.456465 CHC agudo 0.334135 denominación hepatitis no-A 0.402257 hepatocellular carcinoma 0.818192 Concurrent hepatitis 0.385001 Instituto Nacional 0.321684 Qidong hepatitis 0.385791 patients with chronic 0.340288 hígado llamada cirrosis 0.31992 hepatitis nanb 0.397414 risk factors 0.334046 hepatitis b 0.815878 hepatitis c 0.64216 Estados Unidos 0.516836 virus hepáticos forma 0.324783 Universal hepatitis 0.404867 Spanish patients with 0.316748 PDQ Prevención 0.319178	patients with 0.420437 carcinoma among patients 0.322468 SEER Cancer Statistics 0.314302 Rizzetto M 0.316034 Infect Dis 0.316615 virus carriers with 0.326772 natural history 0.314507 Ningún virus 0.321223 hepatocelular factores causales 0.320088 Viral Hepatitis FAQs 0.396943 National Cancer Institute 0.335176 La hepatitis 0.94804 Chang MH 0.316907 viral hepatitis 0.515061 Yuan JM 0.316452 GB virus 0.317604 correlate with expression 0.314623 Long-term phlebotomy with 0.314798 Liver Int 0.354023 Hepatocellular carcinoma without 0.326846 chronic hepatitis 0.450334 hepatitis aguda 0.53174 hepatitis tipos 0.394509 virus rna 0.317794	CLICK HERE
15639	National Cancer Institute	Html	null	Grants	Learn about the different grants that are available, such as Research Projects Grants, SPORE Grants, career awards and cancer education grants, training grants, and others.			CLICK HERE
17242	National Cancer Institute	Html	en	National Cryo-Electron Microscopy Facility Team Members	The National Cryo-Electron Microscopy Facility team is responsible for the operational activities of NCEF. Find team member bios and a list of NCEF working group members.	strategic oversight 0.549362 Lab Advisory Committee 0.88433 Frederick National Lab 0.883241 NCEF Senior Microscopist 0.757617 Molecular Virology 0.5561 government contract projects 0.639164 cancer researchers. 0.551348 Piermaria J. Oddone 0.648956 Thomas Edwards 0.534246 cryo-EM laboratories 0.7289 Grant J. Jensen 0.61562 advisory committee members 0.653176 research expertise 0.57237 PMP certification 0.536505 structural biology 0.656766 Advanced Computer Studies 0.527736 L. Mario Amzel 0.617619 NCEF Scientific Project 0.683141 Biophysics Section 0.560804 Stephen C. Harrison 0.611643 structural studies 0.552951 resolution cryo-electron microscopy 0.682528 structural biology communities 0.646732 academic research 0.551259 Hopkins University School 0.630222	Steven J. Ludtke 0.641874 cryo-EM services 0.763943 Senior Investigator 0.530394 Physical Biochemistry 0.552108 Infectious Disease research 0.655231 Sriram Subramaniam 0.554662 Angela M. Gronenborn 0.615627 Ph.D 0.61505 Hong Zhou 0.531963 core team 0.649969 structural analysis 0.55203 Ulrich Baxa 0.572356 Edward H. Egelman 0.618207 Cancer Research 0.549211 NCEF Microscopist 0.616796 National Lab Advisory 0.882693 adjunct faculty appointments 0.637399 strong background 0.529367 Cell Biology 0.534261 Project Management 0.649065 National Cryo-EM Facility 0.904008 Helen Wang 0.529981 single particle cryo-EM 0.833864 electron tomography 0.5462	CLICK HERE